Live Analyst Rating Changes 1348 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Michael Fairbanks
JPM
Michael Fairbanks
Wall Street Analyst
★★★★☆
#584
on 13Foresight · ranked by our own returns
75%
Success Rate
+6.1%
Average Return
3 of 4 calls profitable · +1.2% vs benchmark
📈 Across the calls we could measure, roughly 75% of Michael Fairbanks's ratings turned a profit when each position was held for 1 year — averaging +6.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

11 Buy 3 Hold 0 Sell
Michael's Stock Coverage 3 ratings · 2026-06-18
Company Date Position Consensus Price Target 1-Yr Return
AGX
Argan
Jun 09, 2026 BUY Strong Buy
-24.3% avg upside
5 analysts
$860.00
21.07% Upside
+17.2%
XYL
Xylem
Apr 30, 2026 BUY Strong Buy
+24.3% avg upside
31 analysts
$140.00
25.09% Upside
-6.5%
BMI
Badger Meter
Apr 17, 2026 BUY Buy
+11.5% avg upside
15 analysts
$160.00
19.95% Upside
+6.4%
Michael Fairbanks — Frequently Asked Questions
How accurate are Michael Fairbanks's stock ratings?
Based on the calls 13Foresight could measure, about 75% of Michael's ratings were profitable over a one-year hold, with an average return of +6.1% per rating, or +1.2% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Michael ranked on 13Foresight?
Michael Fairbanks is currently ranked #584 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Michael cover?
Michael most recently has ratings on AGX, XYL, BMI. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.